AI assistant
Unichem Laboratories Ltd. — Major Shareholding Notification 2019
Apr 1, 2019
61109_rns_2019-04-01_cffeaab3-6696-49b1-92ff-093e55406dc1.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Dr. Prakash Mody
Residence : 2/C, Woodlands, 67, Dr. G. D. Mara, Mumbai - 400 026. Tel.: 2353 6940
April 1, 2019
Department of Corporate Services Bombay Stock Exchange Ltd. Phiroze Jeejeebhoy Towers, Dalal Street. Mumbai- 400 001
Mr. Hari K
Asst. Vice President-Operations National Stock Exchange of India Ltd. Exchange Plaza, Bandra-Kurla Complex Bandra (East), Mumbai- 400 051
Scrip Code - 506690
Symbol - UNICHEMLAB
$Sub:$ Disclosures of Shareholding in Unichem Laboratories Limited as on 31st March 2019 under regulation 30(1) and 30(2) of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011.
Dear Sir.
I, being one of the Promoters of Unichem Laboratories Limited, furnish herewith on behalf of the Promoters and Promoter group, the required Disclosure in the format specified under Regulations 30(1) and 30(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 as on March 31, 2019, which we trust you will find in order.
Please acknowledge receipt.
Kindly take the same on your records.
Yours faithfully.
Dr. Prakash A. Modly As Promoter & on behalf of Promoter Group
Mrs. Neema Thakore Copy to: Head - Legal & Company Secretary Unichem Laboratories Limited Unichem Bhavan, Prabhat Estate. Off S.V. Road, Jogeshwari (W) Mumbai 400 102
Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares
and Takeovers) Regulations, 2011
Part-A- Details of Shareholding
| Unichem Laboratories Limited | ||||
|---|---|---|---|---|
| $\left( \left \right \right)$ | Name of the Target Company (TC) | |||
| 2) | Name(s) of the Stock Exchange(s) | National Stock Exchange (NSE) and Bombay Stock | ||
| where the shares of the TC are listed | Exchange (BSE) | |||
| 3) | Particulars of the shareholder(s): | |||
| a) | Name of person(s) together with | |||
| Persons Acting in Concert (PAC) | ||||
| whose total holding (including that in | ||||
| form of shares, warrants, the |
||||
| convertible securities and any other | ||||
| instrument that would entitle the | ||||
| holder to receive shares in the TC) is | ||||
| more than 25% of the voting rights of | ||||
| the TC. | ||||
| Or | ||||
| (b) Name(s) of promoter(s), member of | (1) Dr. Prakash A. Mody | |||
| the promoter group and PAC with | Ms. Anita Prakash Mody (2) |
|||
| him. | (3) Ms. Supriya Prakash Mody | |||
| (4) Ms. Suparna Prakash Mody | ||||
| 4) | Particulars of the shareholding of | Number of | % w.r.t. total | % of total |
| person(s) mentioned at (3) above | Shares | share /voting | diluted share/ | |
| capital wherever | voting capital of | |||
| applicable | $TC$ $(*)$ | |||
| As of March 31, 2019, holding of: | ||||
| a) Shares | ||||
| Dr. Prakash A. Mody | 3,24,19,392 | 46.06 | ||
| Mrs. Anita Prakash Mody | 13,23,400 | 1.88 | ||
| Ms. Supriya Prakash Mody. | 949,936 | 1.35 | ||
| Ms. Suparna Prakash Mody | 949,936 | 1.35 | ||
| b) Voting Rights (otherwise than by | Nil | Nil | Not Applicable | |
| shares) | Nil | Nil | ||
| c) Warrants, | Nil | Nil | ||
| d) Convertible Securities | Nil | Nil | ||
| e) Any other instrument that would | ||||
| entitle the holder to receive shares | ||||
| in the TC. | ||||
| Total | 3,56,42,664 | 50.64 |
Dr. Prakash A. Mody (As Promoter & on behalf of Promoter Group)
Place: Mumbai: Date: April 1, 2019
à.
Part-B** Name of the Target Company:
| Name(s) of the person and Persons Acting in Concert (PAC) with the person |
Whether the person belongs to Promoter/ Promoter group |
|
|---|---|---|
| Dr. Prakash A. Mody | Promoter | |
| Ms. Anita Prakash Mody | Promoter group | |
| Ms. Supriya Prakash Mody | Promoter group | |
| Ms. Suparna Prakash Mody | Promoter group |
Dr. Prakash A. Mody (As Promoter & on behalf of Promoter Group)
Place: Mumbai Date: April 1, 2019
Note:
-
- In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation $30(1)$ is required.
- (*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
(**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.